Description
Monoclonal antibody therapy focuses on engineering immune cells to target specific peptide sequences indicative of disease. An impediment in the continued advancement of this market is the lack of an efficient, inexpensive means of characterization that can be broadly applied to any antibody while still providing high-density data.
Copyright Statement
Download count: 0
Details
Contributors
- Dai, Jennifer T. (Author)
- Stafford, Phillip (Thesis director)
- Diehnelt, Chris (Committee member)
- School of Life Sciences (Contributor)
- W.P. Carey School of Business (Contributor)
- Barrett, The Honors College (Contributor)
Date Created
The date the item was original created (prior to any relationship with the ASU Digital Repositories.)
2018-05
Subjects
Resource Type
Collections this item is in